4.6 Article

Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3′-diindolylmethane (DIM) or Brussels sprouts

Journal

TOXICOLOGY AND APPLIED PHARMACOLOGY
Volume 460, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.taap.2023.116377

Keywords

Benzo[a]pyrene; Brussels sprouts; 3; 3?-diindolylmethane; Human carcinogen dosing; Accelerator mass spectrometry; Toxicokinetics

Ask authors/readers for more resources

Using UPLC-AMS, we found significant first-pass metabolism of [14C]-BaP in humans following oral micro-dosing. This study examined the effect of dietary supplementation with Brussels sprouts or DIM on plasma levels of [14C]-BaP and metabolites. Results showed that both interventions significantly reduced plasma levels of [14C]-BaP and its metabolites, indicating slower absorption and accelerated clearance for certain metabolites.
Utilizing the atto-zeptomole sensitivity of UPLC-accelerator mass spectrometry (UPLC-AMS), we previously demonstrated significant first-pass metabolism following escalating (25-250 ng) oral micro-dosing in humans of [14C]-benzo[a]pyrene ([14C]-BaP). The present study examines the potential for supplementation with Brussels sprouts (BS) or 3,3 '-diindolylmethane (DIM) to alter plasma levels of [14C]-BaP and metabolites over a 48-h period following micro-dosing with 50 ng (5.4 nCi) [14C]-BaP. Volunteers were dosed with [14C]-BaP following fourteen days on a cruciferous vegetable restricted diet, or the same diet supplemented for seven days with 50 g of BS or 300 mg of BR-DIM (R) prior to dosing. BS or DIM reduced total [14C] recovered from plasma by 56-67% relative to non-intervention. Dietary supplementation with DIM markedly increased Tmax and reduced Cmax for [14C]-BaP indic-ative of slower absorption. Both dietary treatments significantly reduced Cmaxvalues of four downstream BaP metabolites, consistent with delaying BaP absorption. Dietary treatments also appeared to reduce the T1/2 and the plasma AUC(0,infinity) for Unknown Metabolite C, indicating some effect in accelerating clearance of this metabolite. Toxicokinetic constants for other metabolites followed the pattern for [14C]-BaP (metabolite profiles remained relatively consistent) and non-compartmental analysis did not indicate other significant alterations. Significant amounts of metabolites in plasma were at the bay region of [14C]-BaP irrespective of treatment. Although the number of subjects and large interindividual variation are limitations of this study, it represents the first human trial showing dietary intervention altering toxicokinetics of a defined dose of a known human carcinogen.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available